The burden of cholera

References

• Abou-Gareeb AH. (1961). Measurement of seasonal variations in endemic cholera in West Bengal. Bull World Health Organ, 25, 93–102.
   Google Scholar
• Aguirre-Macedo ML, Vidal-Martinez VM, Herrera-Silveira JA, Valdés-Lozano DS, Herrera-Rodríguez M, Olvera-Novoa MA. (2008). Ballast water as a vector of coral pathogens in the Gulf of Mexico: The case of the Cayo Arcas coral reef. Mar Pollut Bull, 56, 1570–1577.
   PubMed Web of Science ®Google Scholar
• Ajzenman C, Bizet MC, Dufraisse MP, Falip E, Fournier JM, Etchegorry MG, Haeghebaert S, Isnard H, Le Loc’h H, Mansir T, Quilici ML, Raqbi F, Raud E, Roberto Y, Scanvic A, Senellier M, Sirot S, Tarantola A; Groupes de Gestion des Incidents. (2006). Cases of imported cholera in France, summer 2005. A. Tarantola for the incident management teams. Med Mal Infect, 36, 346–348.
   Google Scholar
• Alam AN, Goff PA, Abdal NM, Rashid MA, Rahaman MM. (1991). Serum ferritin and cholera. A prospective study. Trop Geogr Med, 43, 12–16.
   Google Scholar
• Alam M, Hasan NA, Sadique A, Bhuiyan NA, Ahmed KU, Nusrin S, Nair GB, Siddique AK, Sack RB, Sack DA, Huq A, Colwell RR. (2006). Seasonal cholera caused by Vibrio cholerae serogroups O1 and O139 in the coastal aquatic environment of Bangladesh. Appl Environ Microbiol, 72, 4096–4104.
   Google Scholar
• Albert MJ, Islam D, Nahar S, Qadri F, Falklind S, Weintraub A. (1997). Rapid detection of Vibrio cholerae O139 Bengal from stool specimens by PCR. J Clin Microbiol, 35, 1633–1635.
   Google Scholar
• Albert MJ, Siddique AK, Islam MS, Faruque AS, Ansaruzzaman M, Faruque SM, Sack RB. (1993). Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet, 341, 704.
   PubMed Web of Science ®Google Scholar
• Anstee DJ. (2010). The relationship between blood groups and disease. Blood, 115, 4635–4643.
   PubMed Web of Science ®Google Scholar
• Arakawa T, Chong DK, Langridge WH. (1998). Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat Biotechnol, 16, 292–297.
   PubMed Web of Science ®Google Scholar
• Bentivoglio M, Pacini P. (1995). Filippo Pacini: A determined observer. Brain Res Bull, 38, 161–165.
   PubMed Web of Science ®Google Scholar
• Berche P, Poyart C, Abachin E, Lelievre H, Vandepitte J, Dodin A, Fournier JM. (1994). The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae. J Infect Dis, 170, 701–704.
   Google Scholar
• Bhattacharya SK. (1995). Cholera outbreaks: Role of oral rehydration therapy. J Indian Med Assoc, 93, 237–238.
   Google Scholar
• Bhattacharya SK. (2003). An evaluation of current cholera treatment. Expert Opin Pharmacother, 4, 141–146.
   PubMed Web of Science ®Google Scholar
• Boardman BK, Meehan BM, Fullner Satchell KJ. (2007). Growth phase regulation of Vibrio cholerae RTX toxin export. J Bacteriol, 189, 1827–1835.
   PubMed Web of Science ®Google Scholar
• Boardman BK, Satchell KJ. (2004). Vibrio cholerae strains with mutations in an atypical type I secretion system accumulate RTX toxin intracellularly. J Bacteriol, 186, 8137–8143.
   Google Scholar
• Booth BA, Boesman-Finkelstein M, Finkelstein RA. (1983). Vibrio cholerae soluble hemagglutinin/protease is a metalloenzyme. Infect Immun, 42, 639–644.
   Google Scholar
• Booth BA, Boesman-Finkelstein M, Finkelstein RA. (1984). Vibrio cholerae hemagglutinin/protease nicks cholera enterotoxin. Infect Immun, 45, 558–560.
   PubMedGoogle Scholar
• Borroto RJ. (1997). Ecology of Vibrio cholerae serogroup 01 in aquatic environments. Rev Panam Salud Publica, 1, 3–8.
   Google Scholar
• Boutin JP, Pages F, Migliani R, Chaignat CL, Ivanoff B. (2001). Cholera update at the dawn of the millenium. Med Trop (Mars), 61, 513–520.
   Google Scholar
• Buechner JS, Constantine H, Gjelsvik A. (2004). John Snow and the Broad Street pump: 150 years of epidemiology. Med Health R I, 87, 314–315.
   Google Scholar
• Cairncross S. (1997). More water: Better health. People Planet, 6, 10–11.
   PubMedGoogle Scholar
• Cameron D, Jones IG. (1983). John Snow, the broad street pump and modern epidemiology. Int J Epidemiol, 12, 393–396.
   PubMed Web of Science ®Google Scholar
• Carpenter CC. (1992). The treatment of cholera: Clinical science at the bedside. J Infect Dis, 166, 2–14.
   Google Scholar
• Cash RA, Narasimhan V. (2000). Impediments to global surveillance of infectious diseases: Consequences of open reporting in a global economy. Bull World Health Organ, 78, 1358–1367.
   PubMed Web of Science ®Google Scholar
• Chaignat CL, Monti V. (2007). Use of oral cholera vaccine in complex emergencies: What next? Summary report of an expert meeting and recommendations of WHO. J Health Popul Nutr, 25, 244–261.
   PubMed Web of Science ®Google Scholar
• Chaignat CL, Monti V, Soepardi J, Petersen G, Sorensen E, Narain J, Kieny MP. (2008). Cholera in disasters: Do vaccines prompt new hopes? Expert Rev Vaccines, 7, 431–435.
   PubMed Web of Science ®Google Scholar
• Chandrasekhar MR, Krishna BV, Patil AB. (2008). Changing characteristics of Vibrio cholerae: Emergence of multidrug resistance and non-O1, non-O139 serogroups. Southeast Asian J Trop Med Public Health, 39, 1092–1097.
   PubMedGoogle Scholar
• Chatterjee SN, Chaudhuri K. (2003). Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. Biochim Biophys Acta, 1639, 65–79.
   PubMed Web of Science ®Google Scholar
• Childers BM, Klose KE. (2007). Regulation of virulence in Vibrio cholerae: The ToxR regulon. Future Microbiol, 2, 335–344.
   PubMed Web of Science ®Google Scholar
• Chomvarin C, Jumroenjit W, Chaicumpar K, Namwat W. (2008). Association of ompU gene in Vibrio cholerae from patients and environment with bile resistance. Southeast Asian J Trop Med Public Health, 39, 876–881.
   Google Scholar
• Chowdhury MI, Sheikh A, Qadri F. (2009). Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009. Expert Rev Vaccines, 8, 1643–1652.
   PubMed Web of Science ®Google Scholar
• Ciufecu C, Nacescu N. (1974). Period of survival of some intestinal bacteria in the Cary and Blair preservation and transport medium. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol, 19, 331–338.
   Google Scholar
• Colwell RR. (1996). Global climate and infectious disease: The cholera paradigm. Science, 274, 2025–2031.
   PubMed Web of Science ®Google Scholar
• Colwell RR, Huq A. (1994). Environmental reservoir of Vibrio cholerae. The causative agent of cholera. Ann N Y Acad Sci, 740, 44–54.
   PubMed Web of Science ®Google Scholar
• Colwell RR, Huq A, Islam MS, Aziz KM, Yunus M, Khan NH, Mahmud A, Sack RB, Nair GB, Chakraborty J, Sack DA, Russek-Cohen E. (2003). Reduction of cholera in Bangladeshi villages by simple filtration. Proc Natl Acad Sci USA, 100, 1051–1055.
   PubMed Web of Science ®Google Scholar
• Constantin De Magny G, Colwell RR. (2009). Cholera and climate: A demonstrated relationship. Trans Am Clin Climatol Assoc, 120, 119–28.
   Google Scholar
• Dajer T. (1992). The deadliest wake-up call. Cholera. Links, 9, 7, 25.
   Google Scholar
• Davis BM, Waldor MK. (2003). Filamentous phages linked to virulence of Vibrio cholerae. Curr Opin Microbiol, 6, 35–42.
   PubMed Web of Science ®Google Scholar
• De Haan L, Hirst TR. (2004). Cholera toxin: A paradigm for multi-functional engagement of cellular mechanisms (Review). Mol Membr Biol, 21, 77–92.
   PubMed Web of Science ®Google Scholar
• Deen JL, von Seidlein L, Sur D, Agtini M, Lucas ME, Lopez AL, Kim DR, Ali M, Clemens JD. (2008). The high burden of cholera in children: Comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis, 2, e173.
   PubMed Web of Science ®Google Scholar
• Desenclos JC. (1996). Epidemiology of toxic and infectious risk related to shellfish consumption. Rev Epidemiol Sante Publique, 44, 437–454.
   Google Scholar
• DiRita VJ, Parsot C, Jander G, Mekalanos JJ. (1991). Regulatory cascade controls virulence in Vibrio cholerae. Proc Natl Acad Sci USA, 88, 5403–5407.
   PubMed Web of Science ®Google Scholar
• Dutt AK, Alwi S, Velauthan T. (1971). A shellfish-borne cholera outbreak in Malaysia. Trans R Soc Trop Med Hyg, 65, 815–818.
   PubMed Web of Science ®Google Scholar
• Eberhart-Phillips J, Besser RE, Tormey MP, Koo D, Feikin D, Araneta MR, Wells J, Kilman L, Rutherford GW, Griffin PM, Baron R, Mascola L. (1996). An outbreak of cholera from food served on an international aircraft. Epidemiol Infect, 116, 9–13.
   PubMed Web of Science ®Google Scholar
• Ekra KD, Attoh-Touré H, Bénié BV, Coulibaly D, Koutouan MG, Aka LN, Dagnan SN, Coulibaly A, Douba A, Tiembré I, Odéhouri-Koudou P, Tagliante-Saracino J. (2009). Five years of cholera surveillance in Ivory Coast during social and political crisis, 2001 to 2005. Bull Soc Pathol Exot, 102, 107–109.
   PubMedGoogle Scholar
• Epstein PR. (1993). Algal blooms in the spread and persistence of cholera. BioSystems, 31, 209–221.
   PubMed Web of Science ®Google Scholar
• Estrada-García T, Mintz ED. (1996). Cholera: Foodborne transmission and its prevention. Eur J Epidemiol, 12, 461–469.
   Google Scholar
• Falade AG, Lawoyin T. (1999). Features of the 1996 cholera epidemic among Nigerian children in Ibadan, Nigeria. J Trop Pediatr, 45, 59–62.
   Google Scholar
• Faruque SM, Albert MJ, Mekalanos JJ. (1998). Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev, 62, 1301–1314.
   PubMed Web of Science ®Google Scholar
• Faruque SM, Islam MJ, Ahmad QS, Biswas K, Faruque AS, Nair GB, Sack RB, Sack DA, Mekalanos JJ. (2006). An improved technique for isolation of environmental Vibrio cholerae with epidemic potential: Monitoring the emergence of a multiple-antibiotic-resistant epidemic strain in Bangladesh. J Infect Dis, 193, 1029–1036.
   Google Scholar
• Faruque SM, Islam MJ, Ahmad QS, Faruque AS, Sack DA, Nair GB, Mekalanos JJ. (2005a). Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage. Proc Natl Acad Sci USA, 102, 6119–6124.
   PubMed Web of Science ®Google Scholar
• Faruque SM, Naser IB, Islam MJ, Faruque AS, Ghosh AN, Nair GB, Sack DA, Mekalanos JJ. (2005b). Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci USA, 102, 1702–1707.
   PubMed Web of Science ®Google Scholar
• Faruque SM, Tam VC, Chowdhury N, Diraphat P, Dziejman M, Heidelberg JF, Clemens JD, Mekalanos JJ, Nair GB. (2007). Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage. Proc Natl Acad Sci USA, 104, 5151–5156.
   PubMedGoogle Scholar
• Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, Kaper JB. (1991). Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci USA, 88, 5242–5246.
   PubMed Web of Science ®Google Scholar
• Favre D, Struck MM, Cryz SJ Jr, Viret JF. (1996). Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR. Vaccine, 14, 526–531.
   Google Scholar
• Finkelstein RA, Boesman-Finkelstein M, Chang Y, Häse CC. (1992). Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect Immun, 60, 472–478.
   PubMed Web of Science ®Google Scholar
• Finkelstein RA, Boesman-Finkelstein M, Holt P. (1983). Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc Natl Acad Sci USA, 80, 1092–1095.
   Google Scholar
• Finkelstein RA, Hanne LF. (1982). Purification and characterization of the soluble hemagglutinin (cholera lectin)(produced by Vibrio cholerae. Infect Immun, 36, 1199–1208.
   Google Scholar
• Fontana MR, Monaci E, Yanqing L, Guoming Q, Duan G, Rappuoli R, Pizza M. (2000). IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin. Vaccine, 19, 75–85.
   Google Scholar
• Fournier JM, Quilici ML. (2007). Cholera. Presse Med, 36, 727–739.
   Google Scholar
• Fullner KJ, Lencer WI, Mekalanos JJ. (2001). Vibrio cholerae-induced cellular responses of polarized T84 intestinal epithelial cells are dependent on production of cholera toxin and the RTX toxin. Infect Immun, 69, 6310–6317.
   PubMed Web of Science ®Google Scholar
• Fullner KJ, Mekalanos JJ. (2000). In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J, 19, 5315–5323.
   PubMedGoogle Scholar
• Gabastou JM, Pesantes C, Escalante S, Narváez Y, Vela E, García L, Zabala D, Yadon ZE. (2002). Characteristics of the cholera epidemic of 1998 in Ecuador during El Niño. Rev Panam Salud Publica, 12, 157–164.
   Google Scholar
• Gallardo AA, Risso S, Fajardo MA, Estevao Belchior S. (2004). Characterization of microbial population present in the edible seaweed, Monostroma undulatum, Wittrock. Arch Latinoam Nutr, 54, 337–345.
   Google Scholar
• Ganin VS. (2009). Cholera and war. Voen Med Zh, 330, 83–88.
   Google Scholar
• Ghose AC. (1996). Adherence & colonization properties of Vibrio cholerae & diarrhoeagenic Escherichia coli. Indian J Med Res, 104, 38–51.
   Google Scholar
• Giono-Cerezo S, Zárate A, Gutiérrez L, Valdespino JL. (1994). Antibiotic resistance pattern of 24, 526 strains of Vibrio cholerae O1 isolated in Mexico from 1991 to 1993. Rev Latinoam Microbiol, 36, 257–262.
   Google Scholar
• Glass RI, Holmgren J, Haley CE, Khan MR, Svennerholm AM, Stoll BJ, Belayet Hossain KM, Black RE, Yunus M, Barua D. (1985). Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol, 121, 791–796.
   PubMed Web of Science ®Google Scholar
• Goh KT, Lam S. (1981). Vibrio infections in Singapore. Ann Acad Med Singap, 10, 2–10.
   Google Scholar
• Gopal S, Otta SK, Kumar S, Karunasagar I, Nishibuchi M, Karunasagar I. (2005). The occurrence of Vibrio species in tropical shrimp culture environments; implications for food safety. Int J Food Microbiol, 102, 151–159.
   PubMed Web of Science ®Google Scholar
• Gorbach SL, Banwell JG, Jacobs B, Chatterjee BD, Mitra R, Brigham KL, Neogy KN. (1970). Intestinal microflora in Asiatic cholera. I. “Rice-water” stool. J Infect Dis, 121, 32–37.
   PubMed Web of Science ®Google Scholar
• Griffith DC, Kelly-Hope LA, Miller MA. (2006). Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg, 75, 973–977.
   PubMed Web of Science ®Google Scholar
• Grujic D, Moric O, Zonjic S, Canic M, Djordjevic S, Petrovic T, Pavlovic D, Zivic-Aleksic J, Milosavljevic R, Tasic G. (1991). Laboratory diagnosis of cholera during enterocolitis epidemic at Dimitrovgrad in August and September 1989. Srp Arh Celok Lek, 119, 310–313.
   Google Scholar
• Hare R. (1955). John Snow and the cholera epidemic of 1854. Med World, 82, 183–195.
   Google Scholar
• Häse CC, Finkelstein RA. (1991). Cloning and nucleotide sequence of the Vibrio cholerae hemagglutinin/protease (HA/protease) gene and construction of an HA/protease-negative strain. J Bacteriol, 173, 3311–3317.
   PubMedGoogle Scholar
• Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, White O, Salzberg SL, Smith HO, Colwell RR, Mekalanos JJ, Venter JC, Fraser CM. (2000). DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature, 406, 477–483.
   PubMed Web of Science ®Google Scholar
• Hervio-Heath D, Colwell RR, Derrien A, Robert-Pillot A, Fournier JM, Pommepuy M. (2002). Occurrence of pathogenic vibrios in coastal areas of France. J Appl Microbiol, 92, 1123–1135.
   Google Scholar
• Hill DR. (1992). Immunizations for foreign travel. Yale J Biol Med, 65, 293–315.
   Google Scholar
• Huber KE, Waldor MK. (2002). Filamentous phage integration requires the host recombinases XerC and XerD. Nature, 417, 656–659.
   PubMed Web of Science ®Google Scholar
• Huo A, Xu B, Chowdhury MA, Islam MS, Montilla R, Colwell RR. (1996). A simple filtration method to remove plankton-associated Vibrio cholerae in raw water supplies in developing countries. Appl Environ Microbiol, 62, 2508–2512.
   Google Scholar
• Huq A, Small EB, West PA, Huq MI, Rahman R, Colwell RR. (1983). Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol, 45, 275–283.
   PubMed Web of Science ®Google Scholar
• Huq A, Yunus M, Sohel SS, Bhuiya A, Emch M, Luby SP, Russek-Cohen E, Nair GB, Sack RB, Colwell RR. (2010). Simple sari cloth filtration of water is sustainable and continues to protect villagers from cholera in Matlab, Bangladesh. MBio, 1.
   Google Scholar
• Islam MS, Sharker MA, Rheman S, Hossain S, Mahmud ZH, Islam MS, Uddin AM, Yunus M, Osman MS, Ernst R, Rector I, Larson CP, Luby SP, Endtz HP, Cravioto A. (2009). Effects of local climate variability on transmission dynamics of cholera in Matlab, Bangladesh. Trans R Soc Trop Med Hyg, 103, 1165–1170.
   PubMed Web of Science ®Google Scholar
• Jensen MA, Faruque SM, Mekalanos JJ, Levin BR. (2006). Modeling the role of bacteriophage in the control of cholera outbreaks. Proc Natl Acad Sci USA, 103, 4652–4657.
   PubMed Web of Science ®Google Scholar
• Jiang SC, Matte M, Matte G, Huq A, Colwell RR. (2000). Genetic diversity of clinical and environmental isolates of Vibrio cholerae determined by amplified fragment length polymorphism fingerprinting. Appl Environ Microbiol, 66, 148–153.
   Google Scholar
• Johnson JA, Morris JG Jr, Kaper JB. (1993). Gene encoding zonula occludens toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in Vibrio cholerae. J Clin Microbiol, 31, 732–733.
   Google Scholar
• Kaper JB, Morris JG Jr, Levine MM. (1995). Cholera. Clin Microbiol Rev, 8, 48–86.
   PubMed Web of Science ®Google Scholar
• Kaper JB, Srivastava BS. (1992). Genetics of cholera toxin. Indian J Med Res, 95, 163–167.
   Google Scholar
• Karki R, Bhatta DR, Malla S, Dumre SP. (2010). Cholera incidence among patients with diarrhea visiting National Public Health Laboratory, Nepal. Jpn J Infect Dis, 63, 185–187.
   PubMed Web of Science ®Google Scholar
• Keen MF, Bujalski L. (1992). The diagnosis and treatment of cholera. Nurse Pract, 17, 53–56.
   Google Scholar
• Khan MU, Shahidullah M, Barua DK, Begum T. (1986). Epidemiological differences between cholera due to multiple antibiotic resistant and multiple antibiotic sensitive Vibrio cholerae infection. Trans R Soc Trop Med Hyg, 80, 60–63.
   Google Scholar
• Khan MU, Shahidullah MD, Haque MS, Ahmed WU. (1984). Presence of vibrios in surface water and their relation with cholera in a community. Trop Geogr Med, 36, 335–340.
   Google Scholar
• Khin Maung U, Greenough WB, 3rd. (1991). Cereal-based oral rehydration therapy. I. Clinical studies. J Pediatr, 118, S72–9.
   Google Scholar
• Kimsey HH, Waldor MK. (1998). Vibrio cholerae hemagglutinin/protease inactivates CTXphi. Infect Immun, 66, 4025–4029.
   PubMedGoogle Scholar
• Kimsey HH, Waldor MK. (2004). The CTXphi repressor RstR binds DNA cooperatively to form tetrameric repressor-operator complexes. J Biol Chem, 279, 2640–2647.
   Google Scholar
• King AA, Ionides EL, Pascual M, Bouma MJ. (2008). Inapparent infections and cholera dynamics. Nature, 454, 877–880.
   PubMed Web of Science ®Google Scholar
• Kirigia JM, Sambo LG, Yokouide A, Soumbey-Alley E, Muthuri LK, Kirigia DG. (2009). Economic burden of cholera in the WHO African region. BMC Int Health Hum Rights, 9, 8.
   PubMedGoogle Scholar
• Koelle K. (2009). The impact of climate on the disease dynamics of cholera. Clin Microbiol Infect, 15 Suppl 1, 29–31.
   Google Scholar
• Koelle K, Rodó X, Pascual M, Yunus M, Mostafa G. (2005). Refractory periods and climate forcing in cholera dynamics. Nature, 436, 696–700.
   PubMed Web of Science ®Google Scholar
• Kossaczka Z, Shiloach J, Johnson V, Taylor DN, Finkelstein RA, Robbins JB, Szu SC. (2000). Vibrio cholerae O139 conjugate vaccines: Synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice. Infect Immun, 68, 5037–5043.
   PubMed Web of Science ®Google Scholar
• Kruse H, Sørum H, Tenover FC, Olsvik O. (1995). A transferable multiple drug resistance plasmid from Vibrio cholerae O1. Microb Drug Resist, 1, 203–210.
   PubMedGoogle Scholar
• Lee JH, Kim MW, Kim BS, Kim SM, Lee BC, Kim TS, Choi SH. (2007). Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J Microbiol, 45, 146–152.
   PubMed Web of Science ®Google Scholar
• Lesmana M, Rockhill RC, Sutanti D, Sutomo A. (1985). An evaluation of alkaline peptone water for enrichment of Vibrio cholerae in feces. Southeast Asian J Trop Med Public Health, 16, 265–267.
   Google Scholar
• Lin W, Fullner KJ, Clayton R, Sexton JA, Rogers MB, Calia KE, Calderwood SB, Fraser C, Mekalanos JJ. (1999). Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci USA, 96, 1071–1076.
   PubMed Web of Science ®Google Scholar
• Lipp EK, Huq A, Colwell RR. (2002). Effects of global climate on infectious disease: The cholera model. Clin Microbiol Rev, 15, 757–770.
   PubMed Web of Science ®Google Scholar
• Lobitz B, Beck L, Huq A, Wood B, Fuchs G, Faruque AS, Colwell R. (2000). Climate and infectious disease: Use of remote sensing for detection of Vibrio cholerae by indirect measurement. Proc Natl Acad Sci USA, 97, 1438–1443.
   PubMed Web of Science ®Google Scholar
• Lopez AL, Clemens JD, Deen J, Jodar L. (2008). Cholera vaccines for the developing world. Hum Vaccin, 4, 165–169.
   PubMed Web of Science ®Google Scholar
• Mahon BE, Mintz ED, Greene KD, Wells JG, Tauxe RV. (1996). Reported cholera in the United States, 1992-1994: A reflection of global changes in cholera epidemiology. JAMA, 276, 307–312.
   PubMed Web of Science ®Google Scholar
• Menzl K, Maier E, Chakraborty T, Benz R. (1996). HlyA hemolysin of Vibrio cholerae O1 biotype E1 Tor. Identification of the hemolytic complex and evidence for the formation of anion-selective ion-permeable channels. Eur J Biochem, 240, 646–654.
   Google Scholar
• Miller CJ, Feachem RG, Drasar BS. (1985). Cholera epidemiology in developed and developing countries: New thoughts on transmission, seasonality, and control. Lancet, 1, 261–262.
   Google Scholar
• Misch A. (1991). Sanitation in the time of cholera. World Watch, 4, 37–38.
   Google Scholar
• Mmwr C. (1993). Imported cholera associated with a newly described toxigenic Vibrio cholerae O139 strain-California, 1993. Mmwr Morb Mortal Wkly Rep, 42, 501–503.
   Google Scholar
• Molla AM, Sarker SA, Hossain M, Molla A, Greenough WB 3rd. (1982). Rice-powder electrolyte solution as oral-therapy in diarrhoea due to Vibrio cholerae and Escherichia coli. Lancet, 1, 1317–1319.
   PubMedGoogle Scholar
• Morris JG Jr.(2003). Cholera and other types of vibriosis: A story of human pandemics and oysters on the half shell. Clin Infect Dis, 37, 272–280.
   PubMed Web of Science ®Google Scholar
• Nair GB, Ramamurthy T, Bhattacharya SK, Mukhopadhyay AK, Garg S, Bhattacharya MK, Takeda T, Shimada T, Takeda Y, Deb BC. (1994a). Spread of Vibrio cholerae O139 Bengal in India. J Infect Dis, 169, 1029–1034.
   Google Scholar
• Nair GB, Shimada T, Kurazono H, Okuda J, Pal A, Karasawa T, Mihara T, Uesaka Y, Shirai H, Garg S. (1994b). Characterization of phenotypic, serological, and toxigenic traits of Vibrio cholerae O139 bengal. J Clin Microbiol, 32, 2775–2779.
   Google Scholar
• Nalin DR. (1976). Cholera, copepods, and chitinase. Lancet, 2, 958.
   Google Scholar
• Nalin DR. (2009). Oral rehydration for cholera. Clin Infect Dis, 48, 839–40; author reply 840.
   Google Scholar
• Nathavitharana KA, Booth IW. (1992). Pharmacoeconomics of the therapy of diarrhoeal disease. Pharmacoeconomics, 2, 305–323.
   Google Scholar
• Nettleman MD. (1991). Cholera, travel, and infection control. Infect Control Hosp Epidemiol, 12, 558–562.
   Google Scholar
• Oeding P. (1990). Cholera in Drammen 1832–the first time in Norway. Tidsskr Nor Laegeforen, 110, 3854–3859.
   Google Scholar
• Pascual M, Bouma MJ, Dobson AP. (2002). Cholera and climate: Revisiting the quantitative evidence. Microbes Infect, 4, 237–245.
   PubMed Web of Science ®Google Scholar
• Paz S. (2009). Impact of temperature variability on cholera incidence in southeastern Africa, 1971-2006. Ecohealth, 6, 340–345.
   PubMed Web of Science ®Google Scholar
• Pearson GD, Woods A, Chiang SL, Mekalanos JJ. (1993). CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc Natl Acad Sci USA, 90, 3750–3754.
   Google Scholar
• Phillips RA. (1964). WATER AND ELECTROLYTE LOSSES IN CHOLERA. Fed Proc, 23, 705–712.
   PubMedGoogle Scholar
• Phillips RA. (1966). Cholera in the perspective of 1966. Ann Intern Med, 65, 922–930.
   PubMed Web of Science ®Google Scholar
• Pillai GV, Brueton MJ, Burston D, Sandhu BK. (1994). Evaluation of the effects of varying solute content on the efficacy of oral rehydration solutions in a rat model of secretory diarrhoea. J Pediatr Gastroenterol Nutr, 18, 457–460.
   Google Scholar
• Rabbani GH. (2000). The search for a better oral rehydration solution for cholera. N Engl J Med, 342, 345–347.
   PubMed Web of Science ®Google Scholar
• Rabbani GH, Greenough WB 3rd. (1999). Food as a vehicle of transmission of cholera. J Diarrhoeal Dis Res, 17, 1–9.
   PubMedGoogle Scholar
• Radu S, Vincent M, Apun K, Abdul-Rahim R, Benjamin PG, Yuherman, Rusul G. (2002). Molecular characterization of Vibrio cholerae O1 outbreak strains in Miri, Sarawak (Malaysia). Acta Trop, 83, 169–176.
   PubMed Web of Science ®Google Scholar
• Ramamurthy T, Garg S, Sharma R, Bhattacharya SK, Nair GB, Shimada T, Takeda T, Karasawa T, Kurazano H, Pal A. (1993). Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet, 341, 703–704.
   PubMed Web of Science ®Google Scholar
• Ranjbar M, Rahmani E, Nooriamiri A, Gholami H, Golmohamadi A, Barati H, Rajabifar D, Barati S, Sabet MS, Zamiri A, Haghighi S, Taifehashemi P, Nojomi M. (2010). High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008. Trop Doct, 40, 214–216.
   Google Scholar
• Reidl J, Klose KE. (2002). Vibrio cholerae and cholera: Out of the water and into the host. FEMS Microbiol Rev, 26, 125–139.
   PubMed Web of Science ®Google Scholar
• Robert A, Silva A, Benitez JA, Rodriguez BL, Fando R, Campos J, Sengupta DK, Boesman-Finkelstein M, Finkelstein RA. (1996). Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A. Vaccine, 14, 1517–1522.
   Google Scholar
• Roychowdhury A, Pan A, Dutta D, Mukhopadhyay AK, Ramamurthy T, Nandy RK, Bhattacharya SK, Bhattacharya MK. (2008). Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India. Jpn J Infect Dis, 61, 128–129.
   Google Scholar
• Sack DA, Sack RB, Nair GB, Siddique AK. (2004). Cholera. Lancet, 363, 223–233.
   PubMed Web of Science ®Google Scholar
• Sack RB, Albert MJ, Siddique AK. (1996). Emergence of Vibrio cholerae O139. Curr Clin Top Infect Dis, 16, 172–193.
   Google Scholar
• Sánchez J, Holmgren J. (2005). Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. Curr Opin Immunol, 17, 388–398.
   PubMed Web of Science ®Google Scholar
• Sanyal SC. (2000). Cholera in its present day scenario. J Indian Med Assoc, 98, 371–376.
   Google Scholar
• Sarah MM., Matthew KW. (2004). Characterization of XerC- and XerD-dependent CTX phage integration in Vibrio cholerae. Molecular Microbiology, 54, 935–947.
   Google Scholar
• Satchell KJ. (2007). MARTX, multifunctional autoprocessing repeats-in-toxin toxins. Infect Immun, 75, 5079–5084.
   PubMed Web of Science ®Google Scholar
• Scarpignato C, Rampal P. (1995). Prevention and treatment of traveler’s diarrhea: A clinical pharmacological approach. Chemotherapy, 41 Suppl 1, 48–81.
   Google Scholar
• Schultz SG. (2007). From a pump handle to oral rehydration therapy: A model of translational research. Adv Physiol Educ, 31, 288–293.
   Google Scholar
• Seas C, DuPont HL, Valdez LM, Gotuzzo E. (1996). Practical guidelines for the treatment of cholera. Drugs, 51, 966–973.
   PubMed Web of Science ®Google Scholar
• Seas C, Gotuzzo E. (1996). Cholera: Overview of epidemiologic, therapeutic, and preventive issues learned from recent epidemics. International Journal of Infectious Diseases, 1, 37–46.
   Google Scholar
• Seshadri R, Joseph SW, Chopra AK, Sha J, Shaw J, Graf J, Haft D, Wu M, Ren Q, Rosovitz MJ, Madupu R, Tallon L, Kim M, Jin S, Vuong H, Stine OC, Ali A, Horneman AJ, Heidelberg JF. (2006). Genome sequence of Aeromonas hydrophila ATCC 7966T: Jack of all trades. J Bacteriol, 188, 8272–8282.
   PubMed Web of Science ®Google Scholar
• Shears P. (1994). Cholera. Ann Trop Med Parasitol, 88, 109–122.
   Web of Science ®Google Scholar
• Siddique AK, Akram K, Zaman K, Mutsuddy P, Eusof A, Sack RB. (1996). Vibrio cholerae O139: How great is the threat of a pandemic? Trop Med Int Health, 1, 393–398.
   Google Scholar
• Siddique AK, Islam Q, Akram K, Mazumder Y, Mitra A, Eusof A. (1989a). Cholera epidemic and natural disasters; where is the link. Trop Geogr Med, 41, 377–382.
   Google Scholar
• Siddique AK, Zaman K, Majumder Y, Islam Q, Bashir I, Mutsuddy P, Eusof A. (1989b). Simultaneous outbreaks of contrasting drug resistant classic and El Tor Vibrio cholerae O1 in Bangladesh. Lancet, 2, 396.
   Google Scholar
• Silva AJ, Pham K, Benitez JA. (2003). Haemagglutinin/protease expression and mucin gel penetration in El Tor biotype Vibrio cholerae. Microbiology (Reading, Engl), 149, 1883–1891.
   Google Scholar
• Sood S, Das BK, Kapil A, Rattan A. (1996). TCBS for the isolation of Vibrio cholerae. Trop Gastroenterol, 17, 177.
   Google Scholar
• Steffen R, Acar J, Walker E, Zuckerman J. (2003). Cholera: Assessing the risk to travellers and identifying methods of protection. Travel Med Infect Dis, 1, 80–88.
   PubMedGoogle Scholar
• Talavera A, Año G, García H, Moreira T, Delgado H, Riverón L, Gil S, Miranda A, Cedré B, Valmaseda T, Pino Y, Pérez JL, Infante JF, García L, Sierra G. (2006). Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638. Vaccine, 24, 3746–3749.
   PubMed Web of Science ®Google Scholar
• Talavera A, Pérez EM. (2009). Is cholera disease associated with poverty? J Infect Dev Ctries, 3, 408–411.
   Google Scholar
• Tarantola A, Ioos S, Lapidus N. (2005). Current cholera epidemics in west Africa and risks of imported cases in European countries. Euro Surveill, 10, E050901.2.
   Google Scholar
• Taylor RK, Kirn TJ, Meeks MD, Wade TK, Wade WF. (2004). A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure. Infect Immun, 72, 6050–6060.
   PubMed Web of Science ®Google Scholar
• Thiagarajah JR, Verkman AS. (2005). New drug targets for cholera therapy. Trends Pharmacol Sci, 26, 172–175.
   PubMed Web of Science ®Google Scholar
• Thiem VD, Deen JL, von Seidlein L, Canh do G, Anh DD, Park JK, Ali M, Danovaro-Holliday MC, Son ND, Hoa NT, Holmgren J, Clemens JD. (2006). Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine, 24, 4297–4303.
   PubMed Web of Science ®Google Scholar
• Thomas J, Josserand C, André LJ. (1974). Physiopathology of diarrhea in cholera. Arch Fr Mal App Dig, 63, 327–341.
   Google Scholar
• Thompson FL, Iida T, Swings J. (2004). Biodiversity of vibrios. Microbiol Mol Biol Rev, 68, 403–31, table of contents.
   Google Scholar
• Trucksis M, Conn TL, Fasano A, Kaper JB. (1997). Production of Vibrio cholerae accessory cholera enterotoxin (Ace) in the yeast Pichia pastoris. Infect Immun, 65, 4984–4988.
   Google Scholar
• Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB. (1993). Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci USA, 90, 5267–5271.
   PubMed Web of Science ®Google Scholar
• Varela P, Pollevick GD, Rivas M, Chinen I, Binsztein N, Frasch AC, Ugalde RA. (1994). Direct detection of Vibrio cholerae in stool samples. J Clin Microbiol, 32, 1246–1248.
   Google Scholar
• Vezzulli L, Pezzati E, Moreno M, Fabiano M, Pane L, Pruzzo C; VibrioSea Consortium. (2009). Benthic ecology of Vibrio spp. and pathogenic Vibrio species in a coastal Mediterranean environment (La Spezia Gulf, Italy). Microb Ecol, 58, 808–818.
   PubMed Web of Science ®Google Scholar
• von Seidlein L. (2007). Vaccines for cholera control: Does herd immunity play a role. PLoS Med, 4, e331.
   Google Scholar
• Waldor MK, Mekalanos JJ. (1996). Lysogenic conversion by a filamentous phage encoding cholera toxin. Science, 272, 1910–1914.
   PubMed Web of Science ®Google Scholar
• Weber JT, Mintz ED, Cañizares R, Semiglia A, Gomez I, Sempértegui R, Dávila A, Greene KD, Puhr ND, Cameron DN. (1994). Epidemic cholera in Ecuador: Multidrug-resistance and transmission by water and seafood. Epidemiol Infect, 112, 1–11.
   Google Scholar
• WHO. (1979). The control of acute diarrhoeal diseases: WHO and UNICEF collaborate in country programmes. WHO Chron, 33, 131–134.
   Google Scholar
• WHO. (1991). Cholera: Ancient scourge on the rise. WHO announces global plan for cholera control. (25 April 1991). WHO Feature, 1–3.
   Google Scholar
• WHO. (1993). Cholera and international trade in food. Bull World Health Organ, 71, 120–121, 127.
   Google Scholar
• WHO. (1995). Cholera in 1994. Part I. Wkly Epidemiol Rec, 70, 201–208.
   Google Scholar
• WHO. (1998). El Nino and its impact on health. Epidemiol Bull, 19, 9–13.
   Google Scholar
• WHO. (2002). WHO Global Task Force on Cholera Control. Cholera vaccines: A new public health tool. 2002. Meeting report. WHO meeting, 10–11 December 2002; Geneva, Switzerland. Report number WHO/CDS/CPE/ZFK/2004.5.
   Google Scholar
• WHO. (2005). WHO Global Task Force on Cholera Control. Oral cholera vaccine use in complex emergencies: What next. 2006. Meeting report. WHO Meeting, 14–16. December 2005; Cairo, Egypt. Report number WHO/CDS/NTD/IDM/2006.2.
   Google Scholar
• WHO. (2007). Cholera, 2006. Wkly Epidemiol Rec, 82, 273–284.
   Google Scholar
• WHO. (2008). Cholera, 2007. Wkly Epidemiol Rec, 83, 269–83.
   Google Scholar
• Wu Z, Nybom P, Magnusson KE. (2000). Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol, 2, 11–17.
   PubMed Web of Science ®Google Scholar
• Wu Z, Nybom P, Sundqvist T, Magnusson KE. (1998). Endogenous nitric oxide in MDCK-I cells modulates the Vibrio cholerae haemagglutinin/protease (HA/P)-mediated cytotoxicity. Microb Pathog, 24, 321–326.
   Google Scholar
• Xu G, Wang S, Zhuang L, Hackett A, Gu L, Zhang L, Zhang C, Wang H, Huang Z, Lu S. (2009). Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera. Vaccine, 27, 3821–3830.
   Web of Science ®Google Scholar
• Zhang RG, Scott DL, Westbrook ML, Nance S, Spangler BD, Shipley GG, Westbrook EM. (1995). The three-dimensional crystal structure of cholera toxin. J Mol Biol, 251, 563–573.
   PubMed Web of Science ®Google Scholar
• Zo YG, Chokesajjawatee N, Grim C, Arakawa E, Watanabe H, Colwell RR. (2009). Diversity and seasonality of bioluminescent Vibrio cholerae populations in Chesapeake Bay. Appl Environ Microbiol, 75, 135–146.
   Google Scholar